These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 19963275)

  • 1. Fibroblast growth factor-inducible 14 (Fn14) is expressed in the lower genital tract and may play a role in amplifying inflammation during infection.
    Han ES; Mekasha S; Ingalls RR
    J Reprod Immunol; 2010 Jan; 84(1):16-23. PubMed ID: 19963275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TWEAK/Fn14 promotes pro-inflammatory cytokine secretion in hepatic stellate cells via NF-κB/STAT3 pathways.
    Wang A; Zhang F; Xu H; Xu M; Cao Y; Wang C; Xu Y; Su M; Zhang M; Zhuge Y
    Mol Immunol; 2017 Jul; 87():67-75. PubMed ID: 28411440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells.
    Campbell S; Burkly LC; Gao HX; Berman JW; Su L; Browning B; Zheng T; Schiffer L; Michaelson JS; Putterman C
    J Immunol; 2006 Feb; 176(3):1889-98. PubMed ID: 16424220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 in patients with polymyositis and dermatomyositis.
    Peng QL; Shu XM; Tian XL; Lu X; Wang GC
    Arthritis Res Ther; 2014 Jan; 16(1):R26. PubMed ID: 24467773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TWEAK/Fn14 interaction stimulates human bronchial epithelial cells to produce IL-8 and GM-CSF.
    Xu H; Okamoto A; Ichikawa J; Ando T; Tasaka K; Masuyama K; Ogawa H; Yagita H; Okumura K; Nakao A
    Biochem Biophys Res Commun; 2004 May; 318(2):422-7. PubMed ID: 15120617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TWEAK/Fn14 pathway is a novel mediator of retinal neovascularization.
    Ameri H; Liu H; Liu R; Ha Y; Paulucci-Holthauzen AA; Hu S; Motamedi M; Godley BF; Tilton RG; Zhang W
    Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):801-13. PubMed ID: 24408972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TWEAK-Fn14 pathway: a potent regulator of skeletal muscle biology in health and disease.
    Tajrishi MM; Zheng TS; Burkly LC; Kumar A
    Cytokine Growth Factor Rev; 2014 Apr; 25(2):215-25. PubMed ID: 24444596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of binding of tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) to fibroblast growth factor inducible 14 (Fn14).
    Fick A; Lang I; Schäfer V; Seher A; Trebing J; Weisenberger D; Wajant H
    J Biol Chem; 2012 Jan; 287(1):484-495. PubMed ID: 22081603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor inducible (Fn14)-specific antibodies concomitantly display signaling pathway-specific agonistic and antagonistic activity.
    Salzmann S; Seher A; Trebing J; Weisenberger D; Rosenthal A; Siegmund D; Wajant H
    J Biol Chem; 2013 May; 288(19):13455-66. PubMed ID: 23532848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TWEAK and Fn14 expression in the pathogenesis of joint inflammation and bone erosion in rheumatoid arthritis.
    Dharmapatni AA; Smith MD; Crotti TN; Holding CA; Vincent C; Weedon HM; Zannettino AC; Zheng TS; Findlay DM; Atkins GJ; Haynes DR
    Arthritis Res Ther; 2011 Mar; 13(2):R51. PubMed ID: 21435232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TWEAK/Fn14 Activation Participates in Skin Inflammation.
    Liu Q; Xiao S; Xia Y
    Mediators Inflamm; 2017; 2017():6746870. PubMed ID: 29038621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low TWEAK expression is correlated to the progression of squamous cervical carcinoma.
    Zou H; Wang D; Gan X; Jiang L; Chen C; Hu L; Zhang Y
    Gynecol Oncol; 2011 Oct; 123(1):123-8. PubMed ID: 21788066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeutics.
    Perez JG; Tran NL; Rosenblum MG; Schneider CS; Connolly NP; Kim AJ; Woodworth GF; Winkles JA
    Oncogene; 2016 Apr; 35(17):2145-55. PubMed ID: 26300004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The TWEAK-Fn14 system as a potential drug target.
    Wajant H
    Br J Pharmacol; 2013 Oct; 170(4):748-64. PubMed ID: 23957828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction between tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 promotes the recruitment of neutrophils into the ischemic brain.
    Haile WB; Echeverry R; Wu J; Yepes M
    J Cereb Blood Flow Metab; 2010 Jun; 30(6):1147-56. PubMed ID: 20068578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression.
    Tran NL; McDonough WS; Savitch BA; Sawyer TF; Winkles JA; Berens ME
    J Biol Chem; 2005 Feb; 280(5):3483-92. PubMed ID: 15611130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TWEAK-independent Fn14 self-association and NF-κB activation is mediated by the C-terminal region of the Fn14 cytoplasmic domain.
    Brown SA; Cheng E; Williams MS; Winkles JA
    PLoS One; 2013; 8(6):e65248. PubMed ID: 23750247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death.
    Nakayama M; Ishidoh K; Kojima Y; Harada N; Kominami E; Okumura K; Yagita H
    J Immunol; 2003 Jan; 170(1):341-8. PubMed ID: 12496418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses.
    Burkly LC; Michaelson JS; Zheng TS
    Immunol Rev; 2011 Nov; 244(1):99-114. PubMed ID: 22017434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease.
    Burkly LC; Michaelson JS; Hahm K; Jakubowski A; Zheng TS
    Cytokine; 2007 Oct; 40(1):1-16. PubMed ID: 17981048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.